HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thomson, D. J. Articles by Cybulsky, I. J. Search for Related Content PubMed PubMed Citation Articles by Thomson, D. J. Articles by Cybulsky, I. J. Related Collections Valve disease

Ann Thorac Surg 2001;71:S269-S272
© 2001 The Society of Thoracic Surgeons

---

Bioprosthetic valves and conduits: new developments

Medtronic mosaic porcine bioprosthesis: midterm investigational trial results

^a Department of Cardiovascular Surgery, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
^b University of British Columbia, Vancouver, British Columbia, Canada
^c Canadian Clinical Investigators of St.-Foy, Quebec, Canada
^d Canadian Clinical Investigators of Regina, Saskatchewan, Canada
^e Canadian Clinical Investigators of Toronto, Ontario, Canada
^f Canadian Clinical Investigators of Halifax, Nova Scotia, Canada
^g Canadian Clinical Investigators of St. John, New Brunswick, Canada
^h Canadian Clinical Investigators of Calgary, Alberta, Canada
ⁱ Canadian Clinical Investigators of Hamilton, Ontario, Canada

Address reprint requests to Dr Thomson, Division of Cardiovascular Surgery, University of Saskatchewan, Royal University Hospital, Saskatoon, SK, S7N 0W8, Canada
e-mail: djthomson{at}home.com

Presented at the VIII International Symposium on Cardiac Bioprostheses, Cancun, Mexico, Nov 3–5, 2000.

Background. The midterm clinical and hemodynamic performance of the Medtronic Mosaic porcine bioprosthesis was evaluated in a regulatory trial.

Methods. In nine Canadian centers, 802 bioprostheses (560 aortic and 242 mitral) were implanted between September 1994 and April 1999 in patients with a mean age of 70 years.

Results. Survival for aortic valve replacement at 4 years was 84.4% ± 3.1%. Freedom from valve-related or unexplained death was 95.6% ± 1.9%; structural valve deterioration, 100.0%; reoperation, 96.2% ± 1.7%; major thromboembolism, 96.1% ± 1.8%; and major antithrombotic-related hemorrhage, 96.4% ±1.7%. Echocardiographic derived mean systolic gradient was 13.4 mm Hg at 4 years with an indexed effective orifice area of 0.7 to 0.8 cm²/m². A significant decrease in left ventricular mass was shown over time in all valve sizes. Survival for mitral valve replacement at 4 years was 79.2% ± 6.8%. Freedom from valve-related or unexplained death was 96.5% ± 3.4%; structural valve deterioration, 100%; reoperation, 97.0% ± 3.2%; major thromboembolism, 95.7% ± 3.8%; and major antithrombotic-related hemorrhage, 95.0% ± 4.2%. Echocardiographically measured averaged mean diastolic gradient was 4.5 mm Hg.

Conclusions. The Medtronic Mosaic bioprosthesis is safe and effective in both the aortic and mitral positions. The valve has low gradients in both positions and excellent left ventricular mass regression in the patients with aortic valve replacement.

This article has been cited by other articles:

				T. Walther, S. Lehmann, V. Falk, S. Metz, N. Doll, A. Rastan, M. Viehweg, M. Richter, J. Gummert, and F. W. Mohr Prospectively Randomized Evaluation of Stented Xenograft Hemodynamic Function in the Aortic Position Circulation, September 14, 2004; 110(11_suppl_1): II-74 - II-78. [Abstract] [Full Text] [PDF]

				N. Vitale, S. C. Clark, A. Ramsden, A. Hasan, C. J. Hilton, and M. P. Holden Clinical and hemodynamic evaluation of small perimount aortic valves in patients aged 75 years or older Ann. Thorac. Surg., January 1, 2003; 75(1): 35 - 39. [Abstract] [Full Text] [PDF]

				T. Gudbjartsson, S. Aranki, and L. H. Cohn Mechanical/Bioprosthetic Mitral Valve Replacement Card. Surg. Adult, January 1, 2003; 2(2003): 951 - 986. [Full Text]